Lineage Cell Therapeutics
Develops off-the-shelf cell-replacement therapies for retinal, spinal-cord, hearing and corneal disease.
$1.11
After-hours close−0.00 (−0.45%)
At close$1.12(−3.88%)
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| Nov 2026 | −$0.03 | — | — |
| Aug 2026 | −$0.03 | −$0.03 | −5.9% |
| May 2026 | −$0.02 | −$0.03 | −50.0% |
| Mar 2026 | −$0.04 | $0.00 | +109.2% |
| Nov 2025 | −$0.02 | −$0.13 | −550.0% |
The latest year is open to everyone — the 41 quarters behind it read with an account. Sign in | |||
| Aug 2025 | |||
| May 2025 | |||
| Mar 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Mar 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Mar 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Mar 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Mar 2021 | |||
| Nov 2020 | |||
| Aug 2020 | |||
| May 2020 | |||
| Mar 2020 | |||
| Nov 2019 | |||
| Aug 2019 | |||
| May 2019 | |||
| Mar 2019 | |||
| Nov 2018 | |||
| Aug 2018 | |||
| May 2018 | |||
| Mar 2018 | |||
| Nov 2017 | |||
| Aug 2017 | |||
| May 2017 | |||
| Mar 2017 | |||
| Nov 2016 | |||
| Aug 2016 | |||
| May 2016 | |||
| Mar 2016 | |||
| Nov 2015 | |||
| Aug 2015 | |||
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise |
|---|---|---|---|---|---|---|
| Nov 5, 2026 | −$0.03 | — | — | $1.3M | — | — |
| Aug 6, 2026 | −$0.03 | −$0.03 | −5.9% | $1.8M | $1.1M | −42.0% |
| May 12, 2026 | −$0.02 | −$0.03 | −50.0% | $3.6M | $1.7M | −52.1% |
| Mar 5, 2026 | −$0.04 | $0.00 | +109.2% | $2.0M | $6.6M | +236.8% |
| Nov 6, 2025 | −$0.02 | −$0.13 | −550.0% | $2.0M | $3.7M | +87.8% |
The latest year is open to everyone — the 41 quarters behind it read with an account. Sign in | ||||||
| Aug 12, 2025 | ||||||
| May 13, 2025 | ||||||
| Mar 10, 2025 | ||||||
| Nov 14, 2024 | ||||||
| Aug 8, 2024 | ||||||
| May 9, 2024 | ||||||
| Mar 7, 2024 | ||||||
| Nov 9, 2023 | ||||||
| Aug 10, 2023 | ||||||
| May 11, 2023 | ||||||
| Mar 9, 2023 | ||||||
| Nov 10, 2022 | ||||||
| Aug 11, 2022 | ||||||
| May 12, 2022 | ||||||
| Mar 10, 2022 | ||||||
| Nov 10, 2021 | ||||||
| Aug 12, 2021 | ||||||
| May 13, 2021 | ||||||
| Mar 11, 2021 | ||||||
| Nov 4, 2020 | ||||||
| Aug 6, 2020 | ||||||
| May 7, 2020 | ||||||
| Mar 12, 2020 | ||||||
| Nov 12, 2019 | ||||||
| Aug 8, 2019 | ||||||
| May 9, 2019 | ||||||
| Mar 14, 2019 | ||||||
| Nov 8, 2018 | ||||||
| Aug 2, 2018 | ||||||
| May 10, 2018 | ||||||
| Mar 15, 2018 | ||||||
| Nov 9, 2017 | ||||||
| Aug 2, 2017 | ||||||
| May 10, 2017 | ||||||
| Mar 16, 2017 | ||||||
| Nov 3, 2016 | ||||||
| Aug 9, 2016 | ||||||
| May 10, 2016 | ||||||
| Mar 15, 2016 | ||||||
| Nov 9, 2015 | ||||||
| Aug 10, 2015 | ||||||